Stock market’s dismal performance is ‘part of the fight against inflation,’ Jim Cramer says

Stock market’s dismal performance is ‘part of the fight against inflation,’ Jim Cramer says


CNBC’s Jim Cramer said Wednesday that while the hot consumer price index suggests the Federal Reserve is losing in its struggle against inflation, the dismal performance of stocks, particularly in the Russell 1000, offers a different view.

“When I talk about the Fed winning or losing the fight against inflation, I mean the fight to tamp down on expensive spending, allowing overstretched supply chains to play catch up, easing some of the strain on the labor market,” the “Mad Money” host said.

“When you look at the collapse of the IPO market and see the stocks in the Russell 1000 … we’re witnessing the most extreme wealth destruction that we’ve seen since the dotcom bust in 2000,” he said. “It’s exactly what the Fed needs on still one more day where a government inflation figure is just too darned hot,” he later added.

Cramer’s comments come after the Bureau of Labor Statistics reported Wednesday that the consumer price index gained 8.3% year-over-year, remaining near 40-year highs.

To illustrate his point, Cramer showed a list of the worst performers in the Russell 1000 put together by CNBC statistician Gina Francolla.

“All of this wealth destruction makes those stocks the trump cards in [Fed Chair] Jay Powell’s” fight to control inflation, Cramer said. “The losses in these names represent the extra vacation, the new roof, the fancy dinner. … These losses slow the economy.”

Here is Cramer’s list of the worst-performing companies in the Russell 1000:

  1. Carvana
  2. Upstart
  3. Skillz
  4. Unity Software
  5. Rivian
  6. TuSimple
  7. Fluence Energy
  8. GoHealth
  9. Wayfair
  10. Novavax
  11. Fastly
  12. Netflix 

“This is a rogue’s gallery of losers that’s expanding every day. … Same with almost all of the IPOs and the SPACs. Their declines are part of the fight against inflation,” Cramer said.



Source

Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More
Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products
Business

Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025. Michael Nagle | Bloomberg | Getty Images Estee Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized […]

Read More
How this French building behemoth wants to solve the U.S. housing dilemma
Business

How this French building behemoth wants to solve the U.S. housing dilemma

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. French […]

Read More